Search

everythinglearnresearchcommunity

for

Search:↓

Precocious puberty is starting earlier due to factors like obesity and chemicals, with treatment focusing on preserving height and addressing social issues.

Androgen receptor overexpression can increase prostate cancer cell growth even without hormones.

A woman had a rare liver tumor causing male-like physical changes, highlighting the need for thorough checks when such symptoms appear.

Early balding may be a sign of future prostate problems.

3α‐OH‐DHP is essential for reducing nerve activity related to blood pressure control during pregnancy.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Delayed puberty often runs in families, can affect growth, and may need hormone treatment.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Adrenal tumors can cause hair loss and high testosterone in women.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Non-classical 21-hydroxylase deficiency can be missed in newborn screenings and should be considered in cases of early puberty or virilization.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Early hair loss may indicate prostate issues.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

Mutations in certain receptors can cause diseases and offer new treatment options.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Atrazine causes birth defects in rats, and finasteride can reliably create a hypospadias model.

Recombinant gonadotropins improve future fertility in CHH patients.

Female hyperandrogenism is a condition caused by too much male hormones, leading to skin issues and ovulation problems, often due to Polycystic Ovary Syndrome, and is treated based on individual symptoms.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.